1.Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Francesca PAPINI ; Niccolò GRASSI ; Giovanni GUGLIELMI ; Vittorio GATTINI ; Lucia RAGO ; Costanza BISORDI ; Monica SCATENI ; Michele TOTARO ; Alberto TULIPANI ; Andrea PORRETTA ; Lara TAVOSCHI ; Jacopo GUERCINI ; Grazia LUCHINI ; Silvia BRIANI ; Gaetano Pierpaolo PRIVITERA ; Angelo BAGGIANI
Environmental Health and Preventive Medicine 2021;26(1):99-99
OBJECTIVES:
In this article, we aim to share our experience in the hospital reorganization made to conduct the SARS-CoV-2 vaccination campaign, based on the principles of flexibility and adaptability.
STUDY DESIGN:
A descriptive study.
METHODS:
The data concerning the organization of the vaccination campaign were taken from the operative protocol developed by the hospital dedicated task force, composed by experts in hygiene, public health, occupational medicine, pharmacists, nurses, hospital quality, and disaster managers. Data about the numbers of vaccine administered daily were collected by the Innovation and Development Operative Unit database.
RESULTS:
Vaccinations against COVID-19 started across the EU on the 27th of December 2020. The first phase of the vaccination campaign carried out in our hospital was directed to healthcare workers immunization including medical residents, social care operators, administrative staff and technicians, students of medicine, and health professions trainees. The second phase was enlarged to the coverage of extremely fragile subjects. Thanks to the massive employment of healthcare workers and the establishment of dynamic pathways, it was possible to achieve short turnaround times and a large number of doses administered daily, with peaks of 870 vaccines per day. From the 27th of December up to the 14th of March a total of 26,341 doses of Pfizer have been administered. 13,584 were first doses and 12,757 were second doses. From the 4th to the 14th of March, 296 first doses of Moderna were dispensed. It was necessary to implement adequate spaces and areas adopting anti-contagion safety measures: waiting area for subjects to be vaccinated, working rooms for the dilution of the vaccine and the storage of the material, vaccination rooms, post-vaccination observation areas, room for observation, and treatment of any adverse reactions, with an emergency cart available in each working area.
CONCLUSIONS
The teaching hospital of Pisa faced the beginning of the immunization campaign readjusting its spaces, planning an adequate hospital vaccination area and providing an organization plan to ensure the achievement of the targets of the campaign. This represented a challenge due to limited vaccine doses supplied and the multisectoral teams of professionals to coordinate in the shortest time and the safest way possible. The organizational model adopted proved to be adequate and therefore exploited also for the second phase aimed to extremely fragile subjects.
2019-nCoV Vaccine mRNA-1273
;
BNT162 Vaccine
;
COVID-19/prevention & control*
;
COVID-19 Vaccines/administration & dosage*
;
Hospitals, Teaching/organization & administration*
;
Humans
;
Immunization Programs/organization & administration*
;
Italy/epidemiology*
;
SARS-CoV-2/immunology*